Document Type : Original Research Article

Authors

1 Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Medical Nanotechnology and Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Infectiologist, Fellowship of prevention and control of nosocomial infections, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

10.22034/hbb.2022.329549.1022

Abstract

Coronavirus disease 2019 (COVID-19), triggered by the new severe acute respiratory syndrome coronavirus 2. Lately, mucormycosis in COVID-19 patients of severe type has been reported. This study was intended to evaluate ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels in COVID-19 patients with mucormycosis. In this study, hospitalized COVID-19 patients with mucormycosis were entered. Information recorded included gender, age, hospitalization and recovery. The laboratory parameters included ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels. Finally, data was analyzed by SPSS software. There was a significant relationship between LDH and CPK level with hospitalization, and also, between CRP and gender. Finally, there was a significant difference between the age groups in terms of ESR. In conclusion, our study showed that LDH and CPK, CRP and ESR should be considered as laboratory tests in the hospitalized COVID-19 patients with mucormycosis.

Keywords